Dr. Akkineni Naga Prasanthi

Qualification: MBBS, DNB (Radiation Oncology)

Experience: 4+ Years

Areas of Specialization:

RADIATION ONCOLOGY, BREAST CANCER

Dr. Akkineni Naga Prasanthi is a consultant radiation oncologist with a particular focus on breast cancer treatment. After completing her postgraduate training at the Apollo Cancer Institute, she joined the Basavatarakam Indo-American Cancer Hospital and Research Institute in the year 2018. Dr. Prasanthi has a research record with numerous peer-reviewed publications. She has been awarded the Dr. Satyapal Agarwal Gold Medal in the specialty of radiation oncology for the DNB Final Examination held in the June 2018 session by the NBE on the 20th convocation. At BIACHRI, Dr. Prasanthi leads clinical research focused on breast cancer.

Memberships:
She is a member of the Association of Radiation Oncologists of India.

Publications:
1. Impact of Anatomical Variations during Intensity Modulated Radiotherapy on Target Volumes, Organs at Risk, and Dose Volume Histograms in Locally Advanced Head and Neck Cancers – A Prospective Interventional Study from Hyderabad, Telangana. Article published in the journal of evidence based medicine and health care in the year 2021.

2. A Dosimetric Comparison between Conventional and Conformal Technique of Chest Wall Radiation in Breast Cancer Patients – A Single Institute Cross Sectional Study at Basavatarakam Indo-American Cancer Hospital and Research Institute. Article published in the journal of evidence based medicine and health care in the year 2021.

3. Quality of Life in Locally Advanced Head and Neck Cancer Patients with Different Radiotherapy Techniques after Definitive Chemo Radiotherapy – A Real-World Data Study with Indian Patients. Article published in the Journal of Evolution of Medical and Dental Sciences in the year 2022.

4. Treatment Delivery within a Helical Geometry in Whole-Breast Radiotherapy on Tomotherapy Machine: is it efficient over Radiation Delivery at Discrete Angles with a Fixed Gantry? Article published in the Cancer Therapy & Oncology International Journal in the year 2022.
5. Feasibility of dose reduction to left anterior descending coronary artery without compromising the target volume coverage using tomotherapy techniques. Article accepted in the Journal of Middle East Journal of Cancer in the year 2022.